查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）
市場調查報告書
商品編碼
1463686

北美新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）

North America Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 94 Pages | 訂單完成後即時交付

價格

2022年北美新生兒篩檢市場價值為5.2155億美元，預計到2030年將達到10.823億美元；預計2022年至2030年CAGR為9.6%。

政府對新生兒篩檢的資金激增推動了北美新生兒篩檢市場

各國政府擴大為新生兒篩檢計畫分配資金。這些計劃有助於降低兒童及其父母的長期醫療費用，因為先天性和遺傳性疾病如果未被發現，可能會導致嚴重的健康併發症和廣泛的醫療干預。透過識別和解決嬰兒期的健康問題，政府可以增強公民的健康和福祉。因此，新生兒篩檢符合更廣泛的公共衛生目標，以改善整體人口健康並減輕醫療保健系統的負擔。

政府資助促進了醫療保健取得的公平性，確保所有人都能獲得新生兒篩檢服務，無論社會經濟地位如何。這種包容性對於早期疾病檢測和介入至關重要，因為它可以防止不同人口群體之間醫療保健結果的差異。隨著各國政府繼續透過增加資金和政策支援來優先考慮新生兒篩檢，全球新生兒篩檢市場一直在經歷永續成長。

北美新生兒篩檢市場概況

近年來，北美新生兒篩檢市場經歷了顯著成長。隨著父母和醫療保健專業人員對早期篩檢對於識別和管理先天性疾病重要性的認知不斷提高，對新生兒篩檢服務的需求顯著增加。此外，醫療技術的進步對於增強新生兒篩檢能力至關重要——實驗室的自動化提高了篩檢的準確性、速度和成本效益。這使得醫療專業人員能夠提供全面的新生兒篩檢，涵蓋更廣泛的遺傳和代謝疾病。有利的立法和監管措施也有利於北美的新生兒篩檢市場。許多州和省已經實施了強制性新生兒篩檢計劃，確保所有嬰兒在出生後不久就接受篩檢。例如，美國每個州都將新生兒篩檢作為公共衛生計劃；每年，約有 400 萬名嬰兒根據該計劃接受篩檢，檢查是否患有分娩時不常出現的疾病。德州衛生與公共服務部於 2021 年 6 月開始對新生兒進行脊髓性肌肉萎縮症 (SMA) 篩檢。

遺傳異常和先天性問題盛行率的上升凸顯了新生兒篩檢的重要性。美國國立衛生研究院向布法羅大學的一名研究人員提供了極具競爭力的R01 資助，以領導一項國際項目，該項目旨在顯著提高新生兒篩檢三種罕見且經常致命的遺傳疾病的準確性。此外，美國國立衛生研究院 (NIH) 尤尼斯·甘迺迪·施賴弗國家兒童健康與人類發展研究所還資助了 380 萬美元的五年獎金。因此，隨著意識的提高、技術的進步、支持性政策和先天性疾病盛行率的增加，北美的新生兒篩檢市場正在不斷成長。

北美新生兒篩檢市場收入及 2030 年預測（百萬美元）

北美新生兒篩檢市場細分

北美新生兒篩檢市場根據產品類型、技術、測試類型、最終用戶和國家進行細分。

根據產品類型，北美新生兒篩檢市場分為試劑、檢測試劑盒和儀器。到 2022 年，試劑和檢測試劑盒細分市場將佔據更大的北美新生兒篩檢市場佔有率。儀器部分細分為新生兒疾病篩檢儀器、脈搏血氧儀、新生兒聽力篩檢儀器和其他儀器。

從技術面來看，北美新生兒篩檢市場分為串聯質譜（TMS）、分子檢測、免疫檢測和酵素檢測、脈搏血氧飽和度篩檢技術等技術。 2022 年，脈搏血氧儀篩檢技術領域佔據北美新生兒篩檢市場最大佔有率。

根據測試類型，北美新生兒篩檢市場分為乾血斑測試、聽力篩檢測試、危重先天性心臟病（CCHD）測試和其他測試類型。 2022 年，乾血斑檢測領域佔據北美新生兒篩檢市場最大佔有率。

依最終用戶分類，北美新生兒篩檢市場分為醫院、診所和診斷實驗室。到 2022 年，醫院和診所細分市場將佔據更大的北美新生兒篩檢市場。

按國家/地區分類，北美新生兒篩檢市場分為美國、加拿大和墨西哥。 2022年，美國在北美新生兒篩檢市場佔據主導地位。

Baebies Inc、Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc 和 Waters Corp 是北美新生兒篩檢市場的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美新生兒篩檢市場 - 主要產業動態

  • 主要市場促進因素
    • 政府為新生兒篩檢提供的資金激增
    • 先天性疾病負擔不斷增加
    • 新生兒疾病盛行率不斷增加
  • 主要市場限制
    • 新生兒篩檢政策和實踐缺乏統一
  • 主要市場機會
    • 新生兒基因篩檢
  • 未來的趨勢
    • 機器學習和人工智慧在篩檢中的整合
  • 影響分析：

第 5 章：新生兒篩檢市場 - 北美市場分析

  • 北美新生兒篩檢市場收入，2022 - 2030

第 6 章：北美新生兒篩檢市場 - 2030 年收入和預測 - 按產品類型

  • 概述
  • 2022 年和 2030 年北美新生兒篩檢市場收入佔有率（按產品類型分類）
  • 試劑和檢測試劑盒
  • 儀器

第 7 章：北美新生兒篩檢市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年北美新生兒篩檢市場收入佔有率（按技術分類）
  • 串聯質譜 (TMS)
  • 分子檢測
  • 免疫測定和酵素測定
  • 脈搏血氧篩檢技術
  • 其他技術

第 8 章：北美新生兒篩檢市場 - 2030 年收入和預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年北美新生兒篩檢市場收入佔有率，按測試類型分類 (%)
  • 乾血斑測試
  • 聽力篩檢測試
  • 嚴重先天性心臟病 (CCHD) 測試
  • 其他測試類型

第 9 章：北美新生兒篩檢市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年北美新生兒篩檢市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診所
  • 診斷實驗室

第 10 章：北美新生兒篩檢市場 - 國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 11 章：北美新生兒篩檢市場-產業格局

  • 概述
  • 新生兒篩檢市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Baebies Inc
  • Medtronic Plc

第 13 章：附錄

Product Code: BMIRE00029603

The North America newborn screening market was valued at US$ 521.55 million in 2022 and is expected to reach US$ 1,082.30 million by 2030; it is estimated to grow at a CAGR of 9.6% from 2022 to 2030.

Surging Government Funding for Newborn Screening Fuels the North America Newborn Screening Market

Governments of different countries are increasingly allocating funds for newborn screening programs. These programs help reduce long-term healthcare costs for children and their parents as congenital and genetic disorders could result in severe health complications and extensive medical interventions if left undetected. By identifying and addressing health issues in infancy, governments can enhance the health and well-being of their citizens. Thus, newborn screening aligns with broader public health objectives to improve overall population health and reduce the burden on healthcare systems.

Government funding promotes equity in healthcare access, ensuring that newborn screening services are available to all, regardless of socioeconomic status. This inclusivity is essential for early disease detection and intervention, as it prevents disparities in healthcare outcomes among different demographic groups. As governments continue to prioritize newborn screening through increased funding and policy support, the newborn screening market has been experiencing sustainable growth worldwide.

North America Newborn Screening Market Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-automation in laboratories has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborn for Spinal Muscular Atrophy (SMA) in June 2021.

The rising prevalence of genetic abnormalities and congenital problems has highlighted the significance of newborn screening. The National Institutes of Health has given a researcher from the University at Buffalo a highly competitive R01 grant to lead an international project developed as an effort to significantly increase the accuracy of newborn screening for three rare, frequently fatal genetic diseases. Further, the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH funds the US$ 3.8 million five-year award. Thus, the newborn screening market in North America is increasing with increased awareness, technological advancements, supportive policies, and growing congenital disorder prevalence.

North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

North America Newborn Screening Market Segmentation

The North America newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the North America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger North America newborn screening market share in 2022. The reagents and assay segment kits is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the North America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest North America newborn screening market share in 2022.

Based on test type, the North America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest North America newborn screening market share in 2022.

By end user, the North America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger North America newborn screening market share in 2022.

Based on country, the North America newborn screening market is categorized into the US, Canada, and Mexico. The US dominated the North America newborn screening market in 2022.

Baebies Inc, Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the North America newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - North America Market Analysis

  • 5.1 North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 North America Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Newborn Screening Market - Country Analysis

  • 10.1 North America Newborn Screening Market, Revenue and Forecast To 2030
    • 10.1.1 North America Newborn Screening Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. North America Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PerkinElmer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Waters Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bio-Rad Laboratories Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Masimo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Natus Medical Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Baebies Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medtronic Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Newborn Screening Market Segmentation
  • Table 2. North America Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 23. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 24. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. North America Newborn Screening Market Segmentation, By Country
  • Figure 2. North America Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in Newborn Screening Market